Literature DB >> 19058261

Treatment-resistant depression: recent developments and future directions.

Sanjay J Mathew1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19058261      PMCID： PMC2933841          DOI： 10.1002/da.20540

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN： 1091-4269            Impact factor:   6.505


× No keyword cloud information.
  17 in total

1.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

2.  Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

Authors:  A John Rush; Lauren B Marangell; Harold A Sackeim; Mark S George; Stephen K Brannan; Sonia M Davis; Robert Howland; Mitchel A Kling; Barry R Rittberg; William J Burke; Mark H Rapaport; John Zajecka; Andrew A Nierenberg; Mustafa M Husain; David Ginsberg; Robert G Cooke
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

3.  Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?

Authors:  Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin
Journal:  Neuropsychopharmacology       Date:  2002-02       Impact factor: 7.853

Review 4.  Research issues in the study of difficult-to-treat depression.

Authors:  A John Rush; Michael E Thase; Sanjay Dubé
Journal:  Biol Psychiatry       Date:  2003-04-15       Impact factor: 13.382

5.  Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

Authors:  John P O'Reardon; H Brent Solvason; Philip G Janicak; Shirlene Sampson; Keith E Isenberg; Ziad Nahas; William M McDonald; David Avery; Paul B Fitzgerald; Colleen Loo; Mark A Demitrack; Mark S George; Harold A Sackeim
Journal:  Biol Psychiatry       Date:  2007-06-14       Impact factor: 13.382

6.  Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

Authors:  Giacomo Salvadore; Brian R Cornwell; Veronica Colon-Rosario; Richard Coppola; Christian Grillon; Carlos A Zarate; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2008-09-25       Impact factor: 13.382

7.  The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Robert M Berman; Ronald N Marcus; René Swanink; Robert D McQuade; William H Carson; Patricia K Corey-Lisle; Arif Khan
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

8.  Effectiveness of electroconvulsive therapy in community settings.

Authors:  Joan Prudic; Mark Olfson; Steven C Marcus; Rice B Fuller; Harold A Sackeim
Journal:  Biol Psychiatry       Date:  2004-02-01       Impact factor: 13.382

9.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

10.  Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

Authors:  Daniel Souery; Pierre Oswald; Isabelle Massat; Ursula Bailer; Joseph Bollen; Koen Demyttenaere; Siegfried Kasper; Yves Lecrubier; Stuart Montgomery; Alessandro Serretti; Joseph Zohar; Julien Mendlewicz
Journal:  J Clin Psychiatry       Date:  2007-07       Impact factor: 4.384
View more
  13 in total

Review 1.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

2.  Identification and management of cryptic bipolarity in patients with TRD.

Authors:  Verinder Sharma
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

3.  Accelerated TMS for Depression: A systematic review and meta-analysis.

Authors:  A Irem Sonmez; Deniz Doruk Camsari; Aiswarya L Nandakumar; Jennifer L Vande Voort; Simon Kung; Charles P Lewis; Paul E Croarkin
Journal:  Psychiatry Res       Date:  2018-12-07       Impact factor: 3.222

4.  Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy.

Authors:  Inmaculada Tasset; René Drucker-Colín; José Peña; Ignacio Jimena; Pedro Montilla; Francisco Javier Medina; Isaac Túnez
Journal:  Neurochem Res       Date:  2010-04-29       Impact factor: 3.996

5.  Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Authors:  James W Murrough; Andrew M Perez; Sarah Pillemer; Jessica Stern; Michael K Parides; Marije aan het Rot; Katherine A Collins; Sanjay J Mathew; Dennis S Charney; Dan V Iosifescu
Journal:  Biol Psychiatry       Date:  2012-07-27       Impact factor: 13.382

6.  Current nosology of treatment resistant depression: a controversy resistant to revision.

Authors:  Michele Fornaro; Patricia Giosuè
Journal:  Clin Pract Epidemiol Ment Health       Date:  2010-05-04

7.  GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.

Authors:  Rong-Jian Liu; Manabu Fuchikami; Jason M Dwyer; Ashley E Lepack; Ronald S Duman; George K Aghajanian
Journal:  Neuropsychopharmacology       Date:  2013-05-17       Impact factor: 7.853

Review 8.  Cortico-Basal Ganglia reward network: microcircuitry.

Authors:  Susan R Sesack; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?

Authors:  Rajarshi Guha Thakurta; Paramita Ray; Dipankar Kanji; Ranjan Das; Bikash Bisui; Om Prakash Singh
Journal:  Indian J Psychol Med       Date:  2012-01

10.  Depression as a risk factor for adverse outcomes in coronary heart disease.

Authors:  Kenneth E Freedland; Robert M Carney
Journal:  BMC Med       Date:  2013-05-15       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.